sugammadex

FDA Drug Profile — sugammadex, Sugammadex, BRIDION

sugammadex is listed in the FDA National Drug Code directory with 23 NDC codes, marketed under brand names including sugammadex, Sugammadex, BRIDION. Available dosage form: injection, solution.

Drug details

Generic Name
sugammadex
Brand Names
sugammadex, Sugammadex, BRIDION
Application Number
ANDA214306
Sponsor
Accord Healthcare Inc.
NDC Codes
23
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
SUGAMMADEX SODIUM

Indications and Usage

1 INDICATIONS AND USAGE Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. Additional pediatric use information is approved for Merck Sharp & Dohme LLC's BRIDION ® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC's marketing exclusivity rights, this drug product is not labeled with that information. Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.